| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.064 | 0.1 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.1 |